Home/Filings/4/0001714899-24-000199
4//SEC Filing

SATO VICKI L 4

Accession 0001714899-24-000199

CIK 0001714899other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:17 PM ET

Size

4.8 KB

Accession

0001714899-24-000199

Insider Transaction Report

Form 4
Period: 2024-09-13
SATO VICKI L
Director
Transactions
  • Sale

    Common Stock

    2024-09-13$30.00/sh1,020$30,600115,156 total
Footnotes (2)
  • [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
  • [F2]Includes 5,967 unvested RSUs.

Issuer

Denali Therapeutics Inc.

CIK 0001714899

Entity typeother

Related Parties

1
  • filerCIK 0001197020

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:17 PM ET
Size
4.8 KB